|
MRK's Operating Income Growth by Quarter and Year
Merck And Co Inc 's Operating Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Operating Income Growth Y/Y▼
|
Operating Income Growth Y/Y▼
|
| MRK Operating Income (in millions $) |
FY 2021 |
FY 2020 |
FY 2019 |
FY 2018 |
| IV Quarter |
December |
-
|
-2,249.00
|
2,567.00
|
2,714.00
|
| III Quarter |
September |
-
|
3,116.00
|
2,382.00
|
2,493.00
|
| II Quarter |
June |
-
|
3,129.00
|
3,399.00
|
2,038.00
|
| I Quarter |
March |
3,014.00
|
3,909.00
|
3,255.00
|
1,054.00
|
| FY |
|
3,014.00
|
7,905.00
|
11,603.00
|
8,299.00
|
| MRK Operating Income first quarter 2021 Y/Y Growth Comment |
Merck And Co Inc reported decline in Operating Income in the first quarter by -22.9% to $ 3,014.00 millions, from the same quarter in 2020.
The contraction in the first quarter Merck And Co Inc 's Operating Income compares unfavorably to the Company's average Operating Income increase of 17.41%.
Looking into first quarter results within Major Pharmaceutical Preparations industry 35 other companies have achieved higher Operating Income growth. While Merck And Co Inc ' s Operating Income fall of -22.9% ranks overall at the positon no. 1644 in the first quarter.
Explain Operating Income growth
|
| MRK Operating Income ( Y/Y Growth %) |
2021
|
2020 |
2019 |
2018 |
| IV Quarter |
December |
- |
- |
-5.42 % |
45.84 % |
| III Quarter |
September |
- |
30.81 % |
-4.45 % |
2086.84 % |
| II Quarter |
June |
- |
-7.94 % |
66.78 % |
-18.38 % |
| I Quarter |
March |
-22.9 % |
20.09 % |
208.82 % |
-48.86 % |
| FY |
|
- |
-31.87 % |
39.81 % |
27.03 % |
MRK Operating Income (Quarter on Quarter Growth %) |
2021
|
2020 |
2019 |
2018 |
| IV Quarter |
December |
- |
- |
7.77 % |
8.86 % |
| III Quarter |
September |
- |
-0.42 % |
-29.92 % |
22.33 % |
| II Quarter |
June |
- |
-19.95 % |
4.42 % |
93.36 % |
| I Quarter |
March |
- |
52.28 % |
19.93 % |
-43.36 % |
| FY (Year on Year) |
|
- |
-31.87 % |
39.81 % |
27.03 % |
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 1067.22 % |
17.41 % |
-89.25 % |
| (Dec. 30, 2008) |
|
(Dec. 30, 2007) |
|
|
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 1067.22 % |
17.41 % |
-89.25 % |
| (Dec. 30, 2008) |
|
(Dec. 30, 2007) |
|
| Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021 |
Merck And Co Inc 's Q/Q Operating Income Growth
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 1532.46 % |
36.98 % |
-95.43 % |
| (Dec 31 2017) |
|
|
| MRK's I. Quarter Q/Q Operating Income Comment |
I. Quarter 2021Cyclical Merck and Co Inc in the factors Operating Loss of $ 3,014.00 millionsCyclical factors have led to Merck and Co Inc 's return to profitability, as MRK deliverOperating Income of $ 3,014.00 millions in the I. Quarter 2021 emanate Operating Loss-2,249.00 millions in the forth quarter. Merck and Co Inc announced in the I. Quarter 2021 Operating Income of $ 3,014.00 millions compare to Operating Loss recorded in previos quarter.
Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Operating Income growth. While Merck And Co Inc 's Operating Income growth quarter on quarter, overall rank is 0. |
|
|
|
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 1532.46 % |
36.98 % |
-95.43 % |
| (Dec 31 2017) |
|
|
| MRK's I. Quarter Q/Q Operating Income Comment |
I. Quarter 2021Seasonal Merck and Co Inc in the factors Operating Loss of $ 3,014.00 millionsSeasonal factors have led to Merck and Co Inc 's restoration of profitability, as MRK deliverOperating Income of $ 3,014.00 millions in the I. Quarter 2021 coming of Operating Loss-2,249.00 millions in the forth quarter. Merck and Co Inc announced in the I. Quarter 2021 Operating Income of $ 3,014.00 millions compare to Operating Loss recorded in previos quarter.
Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Operating Income growth. While Merck And Co Inc 's Operating Income growth quarter on quarter, overall rank is 0. |
|
Merck And Co Inc 's 12 Months Operating Income Growth Year on Year
Operating Income TTM Growth |
12 Months Ending
(Mar 31 2021) |
12 Months Ending
(Dec 31 2020) |
12 Months Ending
(Sep 30 2020) |
12 Months Ending
(Jun 30 2020) |
12 Months Ending
(Mar 31 2020) |
| Cumulative Operating Income 12 Months Ending |
$ 7,010.00 |
$ 7,905.00 |
$ 12,721.00 |
$ 11,987.00 |
$ 12,257.00 |
| Y / Y Operating Income Growth (TTM) |
-42.81 % |
-31.87 % |
8.26 % |
1.06 % |
16.73 % |
| Year on Year Operating Income Growth Overall
Ranking |
# 1482 |
# 902 |
# 776 |
# 888 |
# 376 |
| Seqeuential Operating Income Change (TTM) |
-11.32 % |
-37.86 % |
6.12 % |
-2.2 % |
5.64 % |
| Seq. Operating Income Growth (TTM) Overall
Ranking |
# 1852 |
# 1972 |
# 876 |
# 1042 |
# 545 |
| Cumulative Operating Income growth
Comment |
Merck And Co Inc 's cumulative 12 months Operating Income continue to drop, but on the faster rate at -42.81% year on year, at Mar 31 2021 compare to the -31.87% decrease at Dec 31 2020. If the Merck And Co Inc 's fiscal year would end at Mar 31 2021, annual Operating Income would be $7,010 millions.
In the Healthcare sector 105 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 902 to 1482. |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
1067.22 % |
17.41 % |
-89.25 % |
|
|
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
1129.36 % |
62.34 % |
-89.44 % |
|
|
|
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 40 |
| Sector |
# 143 |
| S&P 500 |
# 1852 |
|
| Cumulative Operating Income growth
Comment |
Merck And Co Inc 's cumulative 12 months Operating Income continue to drop, but on the faster rate at -42.81% year on year, at Mar 31 2021 compare to the -31.87% decrease at Dec 31 2020. If the Merck And Co Inc 's fiscal year would end at Mar 31 2021, annual Operating Income would be $7,010 millions.
In the Healthcare sector 105 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 902 to 1482. |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
1067.22 % |
17.41 % |
-89.25 % |
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
1129.36 % |
62.34 % |
-89.44 % |
|
|
|
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 40 |
| Sector |
# 143 |
| S&P 500 |
# 1852 |
|
